BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 35636907)

  • 1. COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus.
    Jakharia N; Subramanian AK; Shapiro AE
    Infect Dis Clin North Am; 2022 Jun; 36(2):397-421. PubMed ID: 35636907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies.
    Goldman JD; Robinson PC; Uldrick TS; Ljungman P
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34117116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronavirus Disease-2019 in the Immunocompromised Host.
    Bertini CD; Khawaja F; Sheshadri A
    Clin Chest Med; 2023 Jun; 44(2):395-406. PubMed ID: 37085228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-titer post-vaccine COVID-19 convalescent plasma for immunocompromised patients during the first omicron surge.
    Tayyar R; Wong LK; Dahlen A; Shu E; Pandey S; Liu AY
    Transpl Infect Dis; 2023 Apr; 25(2):e14055. PubMed ID: 36929619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus Disease-2019 in the Immunocompromised Host.
    Bertini CD; Khawaja F; Sheshadri A
    Infect Dis Clin North Am; 2024 Mar; 38(1):213-228. PubMed ID: 38280765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful second outpatient autologous hematopoietic cell transplant for relapsed POEMS syndrome in a patient with coexisting HIV, HBV and syphilis infections during the COVID-19 pandemic.
    Hernández-Coronado M; Jaime-Pérez JC; Villarreal-Martínez A; Ocampo-Candiani J; Gómez-Almaguer D
    Transpl Immunol; 2021 Aug; 67():101412. PubMed ID: 34020046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patients.
    Nguyen Y; Flahault A; Chavarot N; Melenotte C; Cheminant M; Deschamps P; Carlier N; Lafont E; Thomas M; Flamarion E; Lebeaux D; Charlier C; Rachline A; Guérin C; Ratiney R; Touchard J; Péré H; Rozenberg F; Lanternier F; Arlet JB; Avouac J; Boussaud V; Guillemain R; Vignon M; Thervet E; Scemla A; Weiss L; Mouthon L;
    Clin Microbiol Infect; 2022 Dec; 28(12):1654.e1-1654.e4. PubMed ID: 35926762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccine use in immunocompromised patients: A commentary on evidence and recommendations.
    Duly K; Farraye FA; Bhat S
    Am J Health Syst Pharm; 2022 Jan; 79(2):63-71. PubMed ID: 34455440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of oral tongue cancer among immunocompromised transplant recipients and human immunodeficiency virus-infected individuals in the United States.
    Tota JE; Engels EA; Madeleine MM; Clarke CA; Lynch CF; Ortiz AP; Hernandez BY; Chaturvedi AK
    Cancer; 2018 Jun; 124(12):2515-2522. PubMed ID: 29645080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaplastic large cell lymphoma in human immunodeficiency virus-infected people and solid organ transplant recipients.
    Mahale P; Weisenburger DD; Kahn AR; Gonsalves L; Pawlish K; Koch L; Tirado-Gomez M; Clarke CA; Alverson G; Shiels MS; Engels EA
    Br J Haematol; 2021 Feb; 192(3):514-521. PubMed ID: 32510592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile in Immunocompromised Hosts: A Review of Epidemiology, Risk Factors, Treatment, and Prevention.
    Revolinski SL; Munoz-Price LS
    Clin Infect Dis; 2019 May; 68(12):2144-2153. PubMed ID: 30281082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronavirus disease 2019 in an orthotopic liver transplant recipient living with human immunodeficiency virus.
    Modi AR; Koval CE; Taege AJ; Modaresi Esfeh J; Eghtesad B; Narayanan Menon KV; Quintini C; Miller C
    Transpl Infect Dis; 2020 Oct; 22(5):e13351. PubMed ID: 32500666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic-Resistant Infections and Treatment Challenges in the Immunocompromised Host.
    Dumford DM; Skalweit M
    Infect Dis Clin North Am; 2016 Jun; 30(2):465-489. PubMed ID: 27208768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Travel risk assessment, advice and vaccinations in immunocompromised travellers (HIV, solid organ transplant and haematopoeitic stem cell transplant recipients): A review.
    Aung AK; Trubiano JA; Spelman DW
    Travel Med Infect Dis; 2015; 13(1):31-47. PubMed ID: 25593039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines.
    Yang Y; Iwasaki A
    Curr HIV/AIDS Rep; 2022 Feb; 19(1):5-16. PubMed ID: 34843064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial.
    Bergman P; Blennow O; Hansson L; Mielke S; Nowak P; Chen P; Söderdahl G; Österborg A; Smith CIE; Wullimann D; Vesterbacka J; Lindgren G; Blixt L; Friman G; Wahren-Borgström E; Nordlander A; Gomez AC; Akber M; Valentini D; Norlin AC; Thalme A; Bogdanovic G; Muschiol S; Nilsson P; Hober S; Loré K; Chen MS; Buggert M; Ljunggren HG; Ljungman P; Aleman S;
    EBioMedicine; 2021 Dec; 74():103705. PubMed ID: 34861491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection.
    Kim YJ; Boeckh M; Englund JA
    Semin Respir Crit Care Med; 2007 Apr; 28(2):222-42. PubMed ID: 17458776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sepsis in Immunocompromised Patients Without Human Immunodeficiency Virus.
    McCreery RJ; Florescu DF; Kalil AC
    J Infect Dis; 2020 Jul; 222(Suppl 2):S156-S165. PubMed ID: 32691837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages - United States, January 2023.
    Patel P; Twentyman E; Koumans E; Rosenblum H; Griffin-Blake S; Jackson B; Vagi S
    MMWR Morb Mortal Wkly Rep; 2023 Feb; 72(5):128-131. PubMed ID: 36730033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV/SARS-CoV-2 coinfection: A global perspective.
    Kanwugu ON; Adadi P
    J Med Virol; 2021 Feb; 93(2):726-732. PubMed ID: 32692406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.